T2 Biosystems Inc. (TTOO)
0.11
-0.01 (-12.00%)
At close: Mar 28, 2025, 3:15 PM
0.11
0.00%
After-hours: Mar 28, 2025, 03:15 PM EDT
T2 Biosystems Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Revenue | 7.19M | 22.3M | 28.06M | 18.13M | 8.34M | 10.5M | 4.67M | 4.08M | 2.81M | 119K | 266K | 19K |
| Cost of Revenue | 15.36M | 21.14M | 20.7M | 21.28M | 16.76M | 15.4M | 12.03M | 6.87M | 1.74M | 19.78M | 14.94M | 11.73M |
| Gross Profit | -8.17M | 1.17M | 7.36M | -3.15M | -8.43M | -4.9M | -7.36M | -2.79M | 1.07M | -19.66M | -14.67M | -11.71M |
| Operating Income | -49.66M | -55.51M | -42.97M | -41.36M | -52.06M | -45.09M | -53.85M | -50.88M | -43.38M | -30.68M | -19.69M | -14.65M |
| Interest Income | n/a | 8K | 112K | 14K | 1K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Pretax Income | -50.08M | -62.32M | -49.24M | -46.8M | -59.01M | -51.15M | -62.43M | -54.8M | -45.29M | -31.39M | -20.61M | -14.46M |
| Net Income | -50.08M | -63.37M | -53.49M | -49.21M | -63.11M | -51.15M | -62.43M | -54.8M | -45.29M | -31.39M | -20.61M | -14.46M |
| Selling & General & Admin | 24.83M | 30.74M | 28.53M | 21.29M | 27.3M | 25.7M | 22.76M | 24.08M | 19.09M | 11.02M | 5.02M | 2.94M |
| Research & Development | 14.15M | 25.93M | 21.8M | 16.92M | 16.33M | 14.49M | 23.73M | 24.01M | 25.36M | 19.78M | 14.94M | 11.73M |
| Other Expenses | 2.51M | 31K | 206K | 62K | 400K | 619K | 331K | 172K | 60K | 12K | -515K | 352K |
| Operating Expenses | 41.49M | 56.68M | 50.33M | 38.21M | 43.63M | 40.19M | 46.49M | 48.09M | 44.46M | 30.8M | 19.96M | 14.67M |
| Interest Expense | 5.34M | 6.08M | 6.59M | 5.5M | 7.35M | 6.68M | 8.91M | 4.1M | 1.97M | 721K | 403K | 154K |
| Selling & Marketing Expenses | n/a | 100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 56.86M | 77.81M | 71.03M | 59.49M | 60.39M | 55.59M | 58.52M | 54.96M | 46.2M | 30.8M | 19.96M | 14.67M |
| Income Tax | n/a | 1.05M | 4.25M | 2.41M | 4.11M | 619K | 9.24M | 1.99M | 562K | 42K | -112K | 506K |
| Shares Outstanding (Basic) | 2.61M | 51K | 31.77K | 24.27K | 9.1K | 405.59K | 321.31K | 260.16K | 205.02K | 86.75K | 13.96K | 139.97K |
| Shares Outstanding (Diluted) | 2.61M | 51K | 31.77K | 24.27K | 9.1K | 405.59K | 321.31K | 260.16K | 205.02K | 86.75K | 13.96K | 139.97K |
| EPS (Basic) | -19.19 | -1.24K | -1.68K | -2.03K | -6.93K | -126.12 | -194.29 | -210.66 | -220.91 | -361.85 | -1.48K | -103.27 |
| EPS (Diluted) | -19.19 | -1.24K | -1.68K | -2.03K | -6.93K | -126.12 | -194.29 | -210.66 | -220.91 | -361.85 | -1.48K | -103.27 |
| EBITDA | -43.88M | -55.2M | -41.13M | -38.49M | -48.3M | -41.96M | -50.58M | -48.43M | -41.86M | -29.98M | -19.62M | -13.73M |
| Depreciation & Amortization | 859K | 2.27M | 2.54M | 3.16M | 3.64M | 2.45M | 2.94M | 2.28M | 1.47M | 691K | 584K | 571K |